Pune, India -- (SBWIRE) -- 11/27/2017 -- MicroDimensions GmbH, Mikroscan Technologies, Inc., Q2 Solutions, Omnyx, LLC, GE Healthcare, Philips Healthcare, Huron Digital Pathology Inc., ViewsIQ Inc., 3DHISTECH Ltd, Apollo Enterprise Imaging Corp., Xifin, Inc., and Definiens are some of the prominent players at the forefront of competition in the Global Digital Pathology Market and are profiled in MRFR Analysis.

Digital Pathology Global Market - Overview

Digital Pathology or Computational Pathology offering completely new perceptions through data analysis, enable pathologists to further consult on treatment options such as in immuno-oncology. Pathology Sectors is a key element of modern diagnostic practice and is evolving with rapid innovation. Traditional histopathology is inefficient and exposes samples to numerous handlers, increasing the scope for human error. On the other hand Digital Pathology, eradicates these risks, while also providing the pathologist with the necessary image and clinical information to generate the most accurate and complete clinical diagnosis. Due to which, Pathology Centres across the globe, are increasingly adopting Digital Pathology to increase diagnostic speeds and accuracy across the country. The Global Digital Pathology Market is growing rapidly demonstrating the growing number of innovations inside the area of pathology which will further increase the market size of Digital Pathology to a great deal, in next six years.

Get a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/1955

Looking at the pervasive growth, the Global Digital Pathology Market is demonstrating currently and considering the potential growth the market will acquire soon; the Market Research Future, promptly published a vivid study report. According to which, the Global Digital Pathology Market is growing rapidly and is expected to gain prominence over the forecast period. The global market of Digital Pathology is estimated to accrue extravagantly by 2022 with a staggering CAGR between 2016 and 2022.

The Global Digital Pathology Market is predominantly driven by the advantages it offers such as speedy processes of diagnosis and further treatment – being one among all. Additionally advanced medical services coupled with burgeoning Healthcare Sector worldwide is fostering the market growth of Digital Pathology vastly. Leverage to the today's social trend; the demand for fast proceedings of treatments, with accurate diagnosis is rising eventually providing impetus to the market growth of Digital Pathology.

"The transition of Digital Pathology to Cloud Pathology, is a predominant trend that we observed during the analysis," The Key Research Analyst, MRFR, states further, "Cloud-based delivery of solutions are increasingly proving to be cost effective as it takes minimal installation time and doesn't need a sophisticated IT infrastructure." The Research Team, MRFR, hopes that these advantages of Cloud Pathology will make Digital Pathology prevailing and will escort it (DP) in to a field where sharing and communication are essential.

Pathologists seem be sceptical towards Digital Pathology, They are coming up with their own set of criteria for adoption. While selecting a vendor, Pathologists or Pathology Centres are looking for user friendly solutions, extensive customer support and extended training hours long before the Price of the solution. This suggests that these three factors - Ease of operation, customer support and training are surprisingly lot more important for Pathology Centers.

Another trend that was noticed during MRFR Analysis was, integration of Artificial Intelligence (AI) technologies in to Digital Pathology. Investors are ready to pour millions of dollars into startups attempting to apply artificial intelligence. And many entrants are getting benefitted with grants of multi million dollars. Technology Experts think that Machine learning and other sophisticated software tools could assist pathologists with analysis, potentially making them more precise and handling some of the monotonous tasks involved in their daily work. And AI truly has the capacity of turning Pathology in to Completely Digital; which is still not digital, for the most part. However, they (Technology Experts) need to ensure that AI technology can reliably process reams of data, and making sure its software can be seamlessly integrated into the workflow of pathologists, who still typically make diagnoses using microscopes and glass slides.

In April 2017, FDA (US) approved of a whole slide imaging system for primary diagnosis. Although in US, the 1st FDA approval, further spurred increased investment among other hardware vendors and sparked renewed interest in digital pathology for clinical use cases across the globe. Medical centers and commercial laboratories are increasingly recognizing that they must adopt digital pathology or be left behind. Early adopters recognize that, while advancements in hardware have enabled the creation of this digital ecosystem, it's the software that's driving value in adoption.

The increased adoption of digital pathology is coinciding with tremendous progress in the ability of computers to recognize complex patterns in images. For the laboratory, computational advances in pathology come in two forms, augmentation and automation, and they often go hand-in-hand. Advances in automation of traditional workflow processes enable pathologists to spend more time on tougher cases, and augmentation provides pathologists with insights about cancer the human eye can't detect.

Digital Pathology Global Market - Competitive Analysis

Although still in its embryonic stage, the global Digital Pathology market seems to be stable industry as far as the eyes can see. Various dynamic and diversified Key Players having international and global presence such as IBM, domestic organizations as well as new entrants form a competitive landscape. Market leaders are innovating continuously and increasingly seeking market expansion through various strategic mergers and acquisitions, innovation, increasing investments in research and development and cost-effective product portfolio. Those players compete based on innovation, product features, quality, cost, and financial stability. Major players are investing on internal R&D activities innovate their already existing products.

Industry/ Innovation/ Related News

Nov. 13, 2017 - ARUP Laboratories, a national pathology reference laboratory, and Applied Spectral Imaging (ASI), a global leader in computer-assisted biomedical imaging, announced their multi-year collaboration, leading to the launch of ASI's PathFusion™, a cutting-edge solution that combines Whole Slide Imaging, industry-leading Tissue FISH analysis and revolutionary digital tissue-matching of FISH with Brightfield samples. PathFusion provides accurate computer-assisted diagnostics for easy FISH validation, bringing pathology closer than ever to FISH.

Nov. 07, 2017 - Inspirata, Inc. (US) Provider of Cancer informatics and digital pathology workflow solutions announced that it has deployed the first group of its Digital Pathology Cockpits for 13 early adopter pathologists. This new digital technology is designed to help improve the cancer diagnostic workflow at The Ohio State University Comprehensive Cancer Center. The Digital Pathology Cockpit is a multi-screen configuration with digital pathology software that supports viewing and manipulating images; provides collaboration, decision support and reporting tools; and has single-sign-on access to all of the patient's diagnostic information and clinical data in one place. Using this system, pathologists can easily access all the information they need to comprehensively review and manage cases, and make precise diagnostic decisions.

Nov. 02, 2017 - Royal Philips, one of the leading health technology provider, announced the launch of a proof-of-concept pilot for digital pathology services at a large, multi-region, scale. The pilot will last up to 12 months and is designed to establish ease-of-adoption for a fully integrated and digitized national pathology service, across Scottish NHS providers.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/digital-pathology-market-1955

Digital Pathology Global Market – Segments

The Digital Pathology Market can be segmented in to 5 key dynamics for the convenience of the report and enhanced understanding;

Segmentation By Types: Comprises Human Pathology and Animal Pathology.

Segmentation By Application: Comprises mHealth, Telemedicine, Disease Diagnosis, Drug Discovery and others.

Segmentation By End Users: Comprises Pharmaceutical Companies, Hospital/Clinics, Reference Laboratories, Research Institutes and others.

Segmentation By Products: Comprises Scanners, Storage Server Systems, Software and others.

Segmentation By Regions: Comprises Geographical regions - North America, Europe, APAC and Rest of the World.

Digital Pathology Global Market – Regional Analysis

Globally North America is the largest market for digital pathology. Europe is the second-largest market. Furthermore Asia pacific market is expected to be the fastest growing market for digital pathology.

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.